Skip to main content
. 2024 Nov 2;43(11):114938. doi: 10.1016/j.celrep.2024.114938

Figure 2.

Figure 2

Fc.Mut24 activates different Foxp3+ TR cell subsets

(A) Number and proliferation (Ki-67) of CD25+ Foxp3+ TR and the expression of indicated TR activation markers. Gates were set on live, CD4+ cells.

(B) Percentage, number, and proliferation of CD44lo CD62Lhi central TR (cTR), CD44hi CD62Lhi central-effector TR (ceTR), and CD44hi CD62Llo effector TR (eTR) in each treatment group. Gates are indicated on representative flow-cytometry plots.

(C) Expression of indicated TR activation markers on TR subsets.

All graphs show mean ± SD with individual data points (n = 6–11); p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗∗p ≤ 0.0001, two-tailed unpaired t tests, or multiple unpaired t tests. n.s., not significant. Data are representative of 2–3 independent experiments.